These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 15938533
1. [Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis]. Iushchuk ND, Znoĭko OO, Safiullina NKh, Dudina KR, Kelli EI, Klimova EA, Kashirin VI, Braginskiĭ DM, Kushlinskiĭ NE, Liubimova NV, Vasilev AIu, Penkina TV, Danilin AG. Ter Arkh; 2005; 77(4):50-5. PubMed ID: 15938533 [Abstract] [Full Text] [Related]
2. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients]. Park JH, Park CK, Kim ES, Park SY, Jo CM, Tak WY, Kweon YO, Kim SK, Choi YW. Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747 [Abstract] [Full Text] [Related]
3. Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis. Lesmana CR, Hasan I, Budihusodo U, Gani RA, Krisnuhoni E, Akbar N, Lesmana LA. J Dig Dis; 2009 Aug; 10(3):201-6. PubMed ID: 19659788 [Abstract] [Full Text] [Related]
4. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance. Zheng M, Cai W, Weng H, Liu R. Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034 [Abstract] [Full Text] [Related]
5. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis. Xie SB, Yao JL, Zheng RQ, Peng XM, Gao ZL. Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650 [Abstract] [Full Text] [Related]
6. The relationship between staging of hepatic fibrosis and the levels of serum biochemistry. Xu GG, Luo CY, Wu SM, Wang CL. Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):246-8. PubMed ID: 14612277 [Abstract] [Full Text] [Related]
7. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis. Xie SB, Yao JL, Zheng SS, Yao CL, Zheng RQ. Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739 [Abstract] [Full Text] [Related]
8. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis. Yilmaz S, Bayan K, Tüzün Y, Dursun M, Kaplan A, Ozmen S, Canoruç F, Akkuş Z. Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611 [Abstract] [Full Text] [Related]
9. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection. Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Muga R. J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132 [Abstract] [Full Text] [Related]
10. [Diagnostic value of five serum markers for liver fibrosis]. Luo R, Yang S, Xie J, Zhao Z, He Y, Yao J. Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388 [Abstract] [Full Text] [Related]
11. [Value of simultaneous determination of serum hyaluronic acid, collagen type IV and the laminin level in diagnosing liver fibrosis]. Liang XH, Zheng H. Hunan Yi Ke Da Xue Xue Bao; 2002 Feb 28; 27(1):67-8. PubMed ID: 12575242 [Abstract] [Full Text] [Related]
12. [Levels of hyaluronic acid in chronic viral C hepatitis with relationship to liver steatosis]. Grzeszczuk A, Łapiński TW, Panasiuk A. Wiad Lek; 2002 Feb 28; 55(1-2):35-41. PubMed ID: 12043313 [Abstract] [Full Text] [Related]
13. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis. Parsian H, Rahimipour A, Nouri M, Somi MH, Qujeq D, Fard MK, Agcheli K. J Gastrointestin Liver Dis; 2010 Jun 28; 19(2):169-74. PubMed ID: 20593050 [Abstract] [Full Text] [Related]
14. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection. Parise ER, Oliveira AC, Figueiredo-Mendes C, Lanzoni V, Martins J, Nader H, Ferraz ML. Liver Int; 2006 Nov 28; 26(9):1095-9. PubMed ID: 17032410 [Abstract] [Full Text] [Related]
15. Serum hyaluronic acid as a marker of hepatic fibrosis. Khan JA, Khan FA, Dilawar M, Ijaz A, Khan NA, Mehmood T. J Coll Physicians Surg Pak; 2007 Jun 28; 17(6):323-6. PubMed ID: 17623578 [Abstract] [Full Text] [Related]
16. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial]. Yin SS, Wang BE, Wang TL, Jia JD, Qian LX. Zhonghua Gan Zang Bing Za Zhi; 2004 Aug 28; 12(8):467-70. PubMed ID: 15329205 [Abstract] [Full Text] [Related]
17. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B]. Chen YP, Feng XR, Dai L, Ding HB, Zhang L. Zhonghua Gan Zang Bing Za Zhi; 2003 Apr 28; 11(4):225-7. PubMed ID: 12716522 [Abstract] [Full Text] [Related]
18. Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver. Tsukamoto T, Yamamoto T, Ikebe T, Takemura S, Shuto T, Kubo S, Hirohashi K, Kinoshita H. Hepatogastroenterology; 2004 Apr 28; 51(57):777-80. PubMed ID: 15143915 [Abstract] [Full Text] [Related]
19. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease. Testa E, Malfatti F, Milazzo S, Cordiviola C, Cotellessa T, Marabotto E, Giannini E, Ceppa P, Mamone M, Risso D, Testa R. Liver Int; 2006 May 28; 26(4):439-44. PubMed ID: 16629647 [Abstract] [Full Text] [Related]
20. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. Patel K, Gordon SC, Jacobson I, Hézode C, Oh E, Smith KM, Pawlotsky JM, McHutchison JG. J Hepatol; 2004 Dec 28; 41(6):935-42. PubMed ID: 15582126 [Abstract] [Full Text] [Related] Page: [Next] [New Search]